Home / Stocks / BNTC

BNTC insider trading

Benitec Biopharma Inc. — open-market insider buys and $1M+ sells from SEC Forms 3, 4 and 5.
Insider buys · 24 mo
8
Bought · 24 mo
$35.7M
Buys · last 90 days
0 · $0
Most recent buy
2025-12-29

Recent insider filings

FiledInsiderTypeSharesPriceValue
2025-12-29Averill Master Fund, Ltd.
Director · 10% owner
Bought144,223$13.20$1.9M
2025-12-22Averill Master Fund, Ltd.
Director · 10% owner
Bought46,141$11.68$539k
2025-11-10Averill Madison Master Fund, Ltd.
Director · 10% owner
Bought1,481,481$13.50$20.0M
2025-04-02Averill Madison Master Fund, Ltd.
Director · 10% owner
Bought16,497$12.83$212k
2025-03-28Averill Madison Master Fund, Ltd.
Director · 10% owner
Bought900,000$13.00$11.7M
2024-12-26Averill Madison Master Fund, Ltd.
Director · 10% owner
Bought47,520$11.09$527k
2024-12-05Averill Madison Master Fund, Ltd.
Director · 10% owner
Bought42,000$9.60$403k
2024-11-21Averill Madison Master Fund, Ltd.
Director · 10% owner
Bought41,436$10.05$417k

Most active insider buyers

InsiderRoleBuysTotal bought
Averill Madison Master Fund, Ltd.Director · 10% owner6$33.3M
Averill Master Fund, Ltd.Director · 10% owner2$2.4M

See BNTC on the chart

Every insider buy and sell for BNTC plotted on the price, the full two-year history, cluster scores and daily updates — in the members area, $29/month. A free quarterly sample of the whole dataset needs no account.

Open the browserFree sample
Data from the SEC EDGAR ownership filings, refreshed daily. Only open-market purchases (transaction code P) and sales of $1M or more are shown; grants, option exercises and tax withholding are excluded because they run on schedules set years earlier. Not investment advice.